• Colon-CSCs are more resistant to chemotherapy than differentiated cancer cells 
INTRODUCTION
In many cancers, a small subpopulation of cells is responsible for tumor-initiation, -growth and metastasis 1 . In the colon, these so called colon cancer stem cells (colon-CSCs) are characterized by the expression of cell surface markers such as CD133 2, 3 , LGR5 4,5 and CD166 6 . Furthermore, these cells display high levels of ALDH1 enzyme activity 7 and Wnt signaling activity 8 . Importantly, colonCSCs show increased resistance to conventional chemotherapies and are believed to be responsible for tumor regeneration after initial response to chemotherapy [9] [10] [11] [12] [13] . Therefore, therapeutic outcomes after chemotherapy may be improved with therapies that specifically target the eradication of colon-CSCs.
Mechanisms that regulate stem cell dynamics in the healthy intestinal epithelium may give fundamental insights into the biology of their malignant counterparts. An important organelle that regulates the homeostasis of normal intestinal stem cells is the endoplasmic reticulum (ER). Novel proteins that are synthesized in the ER are assisted by chaperones for their proper folding. The major ER chaperone GRP78 is in a dynamic equilibrium between folding proteins and ER transmembrane
receptors. An increased load of folding proteins shifts GRP78 away from the transmembrane receptors, a situation termed ER-stress that results in the activation of the unfolded protein response (UPR). We have recently shown that activation of the UPR forces normal intestinal epithelial stem cells into differentiation 14 .
RESULTS

Activation of the Unfolded Protein Response reduces stemness of colon-CSCs
We hypothesized that if the differentiating effects of the Unfolded Protein Response (UPR) would be conserved between normal intestinal stem cells and colon-CSCs, this may be exploited to sensitize colon-CSCs to chemotherapy. To specifically investigate the effects of the UPR on colon-CSCs, we used patient derived spheroid cultures of colon cancer cells with Wnt driven GFP expression 8 . 8, 15 , indicating that the Wnt-driven GFP reporter efficiently distinguishes between CSCs and more differentiated cancer cells.
The UPR can be activated in vitro with subtilase cytotoxin AB (SubAB), a bacterium derived protease that specifically cleaves ER chaperone GRP78 16 . Gene ontology analysis of SubAB treated Wnt high cells
showed that the top three upregulated genesets were: unfolded protein response (p=1.3x10 -36
),
ER associated catabolic process (p=3.9x10 -23 ) and endoplasmic reticulum lumen (p=2.4x10 -22 ).
This confirmed the validity of using SubAB to induce ER-stress and activate the UPR. Interestingly, SubAB treatment resulted in a significant downregulation of several established intestinal stem cell associated genes such as OLFM4 and LGR5 in FACS-sorted colon-CSCs (Wnt-GFP high ) 24 hours posttreatment. (Figure 1a , Figure S1a ). Gene set enrichment analysis (GSEA) using a previously described colon-CSC geneset confirmed the loss of expression of genes that define colon-CSCs 17 ( Figure 1b ).
This suggests that ER-stress results in loss of the colon-CSC phenotype. Indeed, a FACS based analysis showed that treatment with SubAB reduced expression of CD133 and almost completely abrogated expression of LGR5 (Figure 1c ). Similar to SubAB, treatment with the UPR-inducing agent thapsigargin, also resulted in downregulation of stem cell markers, corroborating the results obtained with SubAB ( Figure S1b ). In contrast to thapsigargin and SubAB, salubrinal inhibits the phosphatase of eIF2α
and thereby only activates the PERK-eIF2α branch of the UPR 18 . Interestingly, salubrinal was equally effective in downregulating stem cell markers ( Figure S1c ), suggesting that activation of the PERKeIF2α branch is sufficient for UPR induced differentiation of colon-CSCs, as previously described for normal intestinal stem cells 14 .
To exclude the possibility that LGR5 positive cells disappeared from the spheroid cultures by a process of cell death of the LGR5 positive colon-CSCs, we now FACS-sorted colon-CSCs (Wnt-GFP high )
before start of the treatment (Figure 1d ). Sorted colon-CSCs did not show increased propidium iodide (PI) uptake upon treatment with SubAB ( Figure 1e ) and survived in culture. As previously observed in the unsorted spheroid cultures, LGR5 expression was lost upon treatment ( Figure 1f ).
Together these experiments establish that Wnt-GFP high cells not only lose the transcriptional profile of colon-CSCs but also lose protein expression of the stem cell marker LGR5 when exposed to ERstress.
Self-renewal capacity is a hallmark of stemness and can be determined by limiting dilution analysis.
To test the functional consequences of the ER-stress induced loss of the colon-CSC profile and LGR5
protein expression we performed a limiting dilution assay. Intriguingly, SubAB treatment resulted in a loss of self-renewal capacity in vitro and a decrease in potential to form xenografts in vivo ( Figure   1g ,h), demonstrating that activation of UPR differentiates colon-CSCs both phenotypically as well as functionally.
UPR activation results in differentiation of colon-CSCs towards an enterocyte phenotype
In line with the hypothesis that ER-stress may induce differentiation of colon-CSCs, loss of expression 
UPR induced differentiation sensitizes colon-CSCs to chemotherapy
Colon-CSCs are suggested to be more resistant to conventional chemotherapy and thereby to drive recurrence of the tumor after initial response to therapy. Indeed we found colon-CSCs to be more resistant to oxaliplatin than differentiated cancer cells (Figure 3a , Figure S3 ) confirming previous reports 15 . The specific eradication of these therapy refractory cells may therefore provide a window of opportunity to improve outcomes of chemotherapy. We hypothesized that ER-stress induced colon-CSC differentiation could be an attractive option to achieve this goal. To test this hypothesis, spheroid cultures of colon-CSC were treated with SubAB or salubrinal, followed by conventional 
DISCUSSION
Forced differentiation of colon-CSCs is an attractive and feasible avenue in the development of new strategies to achieve a more sustained response to chemotherapy. Previously, bone morphogenetic protein (BMP) signaling was shown to induce differentiation of colon-CSCs by the inhibition of Wnt signaling, which increased their sensitivity to chemotherapy 21 . This effect however was only found in colon-CSCs that did not have simultaneous mutations in SMAD4 and constitutive activation of PI3K. A more broad effect appears to be exerted by inhibition of the Notch pathway, which strongly suppresses cancer stemness 22 , and in addition neutralizing antibodies against DLL4 were shown to decrease tumor-initiating cell frequency and sensitize colon-CSCs to chemotherapy 23 .
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Chapter 7 
RNA extraction, quantitative RT-PCR and microarray
Spheroid cultures were adhered overnight and treated for 24 hours with SubAB or protease-dead SubA 272 B (1µg/ml). Colon-CSCs (Wnt-GFP high ) were sorted and lysed in 350 µl RLT buffer (RNeasy, QIAGEN). RNA extraction was performed according to manufacturer's instructions. For cDNA synthesis, 1µg of RNA was transcribed using Revertaid (Fermentas). Quantitative RT-PCR was performed using SybrGreen (QIAGEN) according to manufacturers' protocol on a BioRad iCycler using specific primers for the mRNA of interest (see below). For microarray, RNA was labeled using cRNA labeling kit for Illumina arrays (Ambion) and hybridized with Illumina HT12 Arrays. The array data were analyzed on the R2 bioinformatic platform (http://r2.amc.nl). Differentially expressed genes were extracted using ANOVA test (p < 0.05) and FDR post-analysis correction. GSEA were done using GSEA software from the Broad Institute (http://www.broadinstitute.org/gsea). The gene sets used were previously described 17 . Heatmaps were generated using TreeView software generated by the Eisen lab (http://www.eisenlab.org/eisen).
Quantitative RT-PCR primers
See supplemental information
Flow cytometry and FACS sorting
Spheroid cultures were adhered overnight and treated for 24 hours with SubAB or protease-dead 
3D matrigel differentiation assay
For 3D matrigel cultures, trypsin-dissociated spheroid cultures were dissolved in ice cold, liquid matrigel and allowed to solidify at 37° before addition of CSC-medium. Treatment were added to the 3D matrigel cultures two days thereafter and continued for four days. Quantification of differentiated spheres was performed by three independent observers that were blinded for the treatment.
Limiting-dilution Assays
For in vitro limiting-dilutions, spheroid cultures were pre-treated for 24 hours with SubAB or protease- 
Animal experiments
The protocol of this study was approved by the animal ethics committee of the University of Amsterdam (permit number ALC102862 au/software/elda/index.html).
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. All significance was defined as *p<0.05, **p < 0.01, ***p < 0.001.
Accession numbers
Microarray data have been deposited in the Gene Expression Omnibus Database with the accession number GSE65879. ) after indicated treatments. Colon-CSCs were more resistant to oxaliplatin (24 hours, 50µM) compared to differentiated cancer cells. Pre-treatment with salubrinal (24 hours 25µM) resulted in enhanced sensitivity to oxaliplatin induced apoptosis. Mean ± SEM depicted. Significance was measured by two-way anova, followed by Bonferroni posttest for multiple comparisons. Significance was defined as *p<0.05, **p < 0.01, ***p < 0.001.
